CD4 and colitis: Further studies confirmed that BBR inhibited the TH1/TH17-related JAK/STAT pathway of LP CD4+ T cells and mediated IFN-γ and IL-17A production by LP CD4+ T cells through AMPK activation in vivo experiments with colitis SCID mice and in vitro experiments with LP CD4+ T cells [78].